$NEWH

BioSolar Inc

CIK:0001371128|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue:
Operating expenses:
Selling and marketing expenses	109,878	94,092	203,447	200,571
General and administrative expenses	464,318	381,053	861,116	648,506
Research and development	342,874	147,867	674,387	249,385
Depreciation and amortization	821	820	1,642	1,641
Total operating expenses	917,891	623,832	1,740,592	1,100,103
Loss from operations before other income (expense)	(917,891)	(623,832)	(1,740,592)	(1,100,103)
Other income (expense):
Interest income	69	128	173	305
Other expenses			(399)
Total other income (expense)	69	128	(226)	305
Net income (loss)	$ (917,822)	$ (623,704)	$ (1,740,818)	$ (1,099,798)
Basic earnings (loss) per share	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Diluted earnings (loss) per share	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of common shares outstanding, basic	789,922,604	705,126,274	779,037,297	704,861,438
Weighted average number of common shares outstanding, diluted	789,922,604	705,126,274	779,037,297	704,861,438

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (1,740,818)	$ (1,099,798)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	1,642	1,641
Non-cash stock compensation expense	331,333	116,527
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(49,254)	(26,336)
Accounts payable and accrued liabilities	(3,338)	4,351
Net cash provided by (used in) operating activities	(1,460,435)	(1,003,615)
CASH FLOWS FROM INVESTING ACTIVITIES:
CASH FLOWS FROM FINANCING ACTIVITIES:
Common shares issued through an equity financing agreement	763,035
Net cash provided by financing activities	763,035
Net increase (decrease) in cash	(697,400)	(1,003,615)
Cash, cash equivalents, and restricted cash - beginning of period	1,436,928	2,104,521
Cash, cash equivalents, and restricted cash - end of period	739,528	1,100,906
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest
Income taxes
Non-cash investing and financing activities:
Adjustment to mezzanine	39,200
Equity financing cost		$ 30,000

Condensed Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash	$ 739,528	$ 1,436,928
Prepaid expenses and other current assets	55,275	6,021
Total current assets	794,803	1,442,949
Property and equipment:
Machinery and equipment	37,225	37,225
Less: accumulated depreciation	(37,117)	(36,986)
Net property and equipment	108	239
Other assets:
Patents, net of amortization of $31,735 and $30,224, respectively	13,601	15,112
Deposit	770	770
Total other assets	14,371	15,882
Total assets	809,282	1,459,070
Current liabilities:
Accounts payable and accrued liabilities	6,448	9,786
Total current liabilities	6,448	9,786
Mezzanine:
Commitments and contingencies
Stockholders’ equity (deficit):
Preferred stock, $0.0001 par value; 10,000,000 authorized shares
Common stock, $0.0001 par value; 3,000,000,000 authorized shares 814,441,380 and 768,031,041 shares issued and outstanding, respectively	81,444	76,803
Additional paid in capital	179,805,585	178,676,658
Accumulated deficit	(182,530,308)	(180,789,490)
Total stockholders’ deficit	(2,643,279)	(2,036,029)
Total liabilities, mezzanine and stockholders’ equity	809,282	1,459,070
Series C Convertible Preferred Stock [Member]
Mezzanine:
Series C Convertible Preferred Stock, 34,461 and 34,853 shares outstanding, respectively	$ 3,446,113	$ 3,485,313